-
1
-
-
0037021505
-
The metabolic syndrome and total and cardiovascular disease mortality in middle-aged men
-
Lakka HM, Laaksonen DE, Lakka TA, Niskanen LK, Kumpusalo E, et al. (2002) The metabolic syndrome and total and cardiovascular disease mortality in middle-aged men. Jama 288: 2709-2716.
-
(2002)
Jama
, vol.288
, pp. 2709-2716
-
-
Lakka, H.M.1
Laaksonen, D.E.2
Lakka, T.A.3
Niskanen, L.K.4
Kumpusalo, E.5
-
2
-
-
33845522074
-
Dysregulation of the peripheral and adipose tissue endocannabinoid system in human abdominal obesity
-
Bluher M, Engeli S, Kloting N, Berndt J, Fasshauer M, et al. (2006) Dysregulation of the peripheral and adipose tissue endocannabinoid system in human abdominal obesity. Diabetes 55: 3053-3060.
-
(2006)
Diabetes
, vol.55
, pp. 3053-3060
-
-
Bluher, M.1
Engeli, S.2
Kloting, N.3
Berndt, J.4
Fasshauer, M.5
-
3
-
-
25844460609
-
Activation of the peripheral endocannabinoid system in human obesity
-
Engeli S, Bohnke J, Feldpausch M, Gorzelniak K, Janke J, et al. (2005) Activation of the peripheral endocannabinoid system in human obesity. Diabetes 54: 2838-2843.
-
(2005)
Diabetes
, vol.54
, pp. 2838-2843
-
-
Engeli, S.1
Bohnke, J.2
Feldpausch, M.3
Gorzelniak, K.4
Janke, J.5
-
4
-
-
17844411014
-
Overweight and obesity associated with a missense polymorphism in fatty acid amide hydrolase (FAAH)
-
Sipe JC, Waalen J, Gerber A, Beutler E, (2005) Overweight and obesity associated with a missense polymorphism in fatty acid amide hydrolase (FAAH). Int J Obes (Lond) 29: 755-759.
-
(2005)
Int J Obes (Lond)
, vol.29
, pp. 755-759
-
-
Sipe, J.C.1
Waalen, J.2
Gerber, A.3
Beutler, E.4
-
5
-
-
42249099620
-
Dysregulation of peripheral endocannabinoid levels in hyperglycemia and obesity: Effect of high fat diets
-
Matias I, Petrosino S, Racioppi A, Capasso R, Izzo AA, et al. (2008) Dysregulation of peripheral endocannabinoid levels in hyperglycemia and obesity: Effect of high fat diets. Mol Cell Endocrinol 286: S66-78.
-
(2008)
Mol Cell Endocrinol
, vol.286
, pp. 66-78
-
-
Matias, I.1
Petrosino, S.2
Racioppi, A.3
Capasso, R.4
Izzo, A.A.5
-
6
-
-
68349129115
-
Peripheral endocannabinoid dysregulation in obesity: relation to intestinal motility and energy processing induced by food deprivation and re-feeding
-
Izzo AA, Piscitelli F, Capasso R, Aviello G, Romano B, et al. (2009) Peripheral endocannabinoid dysregulation in obesity: relation to intestinal motility and energy processing induced by food deprivation and re-feeding. Br J Pharmacol 158: 451-461.
-
(2009)
Br J Pharmacol
, vol.158
, pp. 451-461
-
-
Izzo, A.A.1
Piscitelli, F.2
Capasso, R.3
Aviello, G.4
Romano, B.5
-
7
-
-
58149471799
-
Changes in plasma endocannabinoid levels in viscerally obese men following a 1 year lifestyle modification programme and waist circumference reduction: associations with changes in metabolic risk factors
-
Di Marzo V, Cote M, Matias I, Lemieux I, Arsenault BJ, et al. (2009) Changes in plasma endocannabinoid levels in viscerally obese men following a 1 year lifestyle modification programme and waist circumference reduction: associations with changes in metabolic risk factors. Diabetologia 52: 213-217.
-
(2009)
Diabetologia
, vol.52
, pp. 213-217
-
-
Di Marzo, V.1
Cote, M.2
Matias, I.3
Lemieux, I.4
Arsenault, B.J.5
-
8
-
-
27844463517
-
Effects of rimonabant on metabolic risk factors in overweight patients with dyslipidemia
-
Despres JP, Golay A, Sjostrom L, (2005) Effects of rimonabant on metabolic risk factors in overweight patients with dyslipidemia. N Engl J Med 353: 2121-2134.
-
(2005)
N Engl J Med
, vol.353
, pp. 2121-2134
-
-
Despres, J.P.1
Golay, A.2
Sjostrom, L.3
-
9
-
-
32644441249
-
Effect of rimonabant, a cannabinoid-1 receptor blocker, on weight and cardiometabolic risk factors in overweight or obese patients: RIO-North America: a randomized controlled trial
-
Pi-Sunyer FX, Aronne LJ, Heshmati HM, Devin J, Rosenstock J, (2006) Effect of rimonabant, a cannabinoid-1 receptor blocker, on weight and cardiometabolic risk factors in overweight or obese patients: RIO-North America: a randomized controlled trial. Jama 295: 761-775.
-
(2006)
Jama
, vol.295
, pp. 761-775
-
-
Pi-Sunyer, F.X.1
Aronne, L.J.2
Heshmati, H.M.3
Devin, J.4
Rosenstock, J.5
-
10
-
-
33751001942
-
Efficacy and tolerability of rimonabant in overweight or obese patients with type 2 diabetes: a randomised controlled study
-
Scheen AJ, Finer N, Hollander P, Jensen MD, Van Gaal LF, (2006) Efficacy and tolerability of rimonabant in overweight or obese patients with type 2 diabetes: a randomised controlled study. Lancet 368: 1660-1672.
-
(2006)
Lancet
, vol.368
, pp. 1660-1672
-
-
Scheen, A.J.1
Finer, N.2
Hollander, P.3
Jensen, M.D.4
Van Gaal, L.F.5
-
11
-
-
17144382751
-
Effects of the cannabinoid-1 receptor blocker rimonabant on weight reduction and cardiovascular risk factors in overweight patients: 1-year experience from the RIO-Europe study
-
Van Gaal LF, Rissanen AM, Scheen AJ, Ziegler O, Rossner S, (2005) Effects of the cannabinoid-1 receptor blocker rimonabant on weight reduction and cardiovascular risk factors in overweight patients: 1-year experience from the RIO-Europe study. Lancet 365: 1389-1397.
-
(2005)
Lancet
, vol.365
, pp. 1389-1397
-
-
Van Gaal, L.F.1
Rissanen, A.M.2
Scheen, A.J.3
Ziegler, O.4
Rossner, S.5
-
12
-
-
42449136138
-
Long-term effect of CB1 blockade with rimonabant on cardiometabolic risk factors: two year results from the RIO-Europe Study
-
Van Gaal LF, Scheen AJ, Rissanen AM, Rossner S, Hanotin C, et al. (2008) Long-term effect of CB1 blockade with rimonabant on cardiometabolic risk factors: two year results from the RIO-Europe Study. Eur Heart J 29: 1761-1771.
-
(2008)
Eur Heart J
, vol.29
, pp. 1761-1771
-
-
Van Gaal, L.F.1
Scheen, A.J.2
Rissanen, A.M.3
Rossner, S.4
Hanotin, C.5
-
13
-
-
0032541111
-
Appetite suppression and weight loss after the cannabinoid antagonist SR 141716
-
Colombo G, Agabio R, Diaz G, Lobina C, Reali R, et al. (1998) Appetite suppression and weight loss after the cannabinoid antagonist SR 141716. Life Sci 63: PL113-117.
-
(1998)
Life Sci
, vol.63
, pp. 113-117
-
-
Colombo, G.1
Agabio, R.2
Diaz, G.3
Lobina, C.4
Reali, R.5
-
14
-
-
85047690626
-
The endogenous cannabinoid system affects energy balance via central orexigenic drive and peripheral lipogenesis
-
Cota D, Marsicano G, Tschop M, Grubler Y, Flachskamm C, et al. (2003) The endogenous cannabinoid system affects energy balance via central orexigenic drive and peripheral lipogenesis. J Clin Invest 112: 423-431.
-
(2003)
J Clin Invest
, vol.112
, pp. 423-431
-
-
Cota, D.1
Marsicano, G.2
Tschop, M.3
Grubler, Y.4
Flachskamm, C.5
-
15
-
-
0035848818
-
Leptin-regulated endocannabinoids are involved in maintaining food intake
-
Di Marzo V, Goparaju SK, Wang L, Liu J, Batkai S, et al. (2001) Leptin-regulated endocannabinoids are involved in maintaining food intake. Nature 410: 822-825.
-
(2001)
Nature
, vol.410
, pp. 822-825
-
-
Di Marzo, V.1
Goparaju, S.K.2
Wang, L.3
Liu, J.4
Batkai, S.5
-
16
-
-
24644500204
-
The CB1 receptor antagonist rimonabant reverses the diet-induced obesity phenotype through the regulation of lipolysis and energy balance
-
Jbilo O, Ravinet-Trillou C, Arnone M, Buisson I, Bribes E, et al. (2005) The CB1 receptor antagonist rimonabant reverses the diet-induced obesity phenotype through the regulation of lipolysis and energy balance. Faseb J 19: 1567-1569.
-
(2005)
Faseb J
, vol.19
, pp. 1567-1569
-
-
Jbilo, O.1
Ravinet-Trillou, C.2
Arnone, M.3
Buisson, I.4
Bribes, E.5
-
17
-
-
0037304290
-
Anti-obesity effect of SR141716, a CB1 receptor antagonist, in diet-induced obese mice
-
Ravinet Trillou C, Arnone M, Delgorge C, Gonalons N, Keane P, et al. (2003) Anti-obesity effect of SR141716, a CB1 receptor antagonist, in diet-induced obese mice. Am J Physiol Regul Integr Comp Physiol 284: R345-353.
-
(2003)
Am J Physiol Regul Integr Comp Physiol
, vol.284
, pp. 345-353
-
-
Ravinet Trillou, C.1
Arnone, M.2
Delgorge, C.3
Gonalons, N.4
Keane, P.5
-
18
-
-
1842866963
-
CB1 cannabinoid receptor knockout in mice leads to leanness, resistance to diet-induced obesity and enhanced leptin sensitivity
-
Ravinet Trillou C, Delgorge C, Menet C, Arnone M, Soubrie P, (2004) CB1 cannabinoid receptor knockout in mice leads to leanness, resistance to diet-induced obesity and enhanced leptin sensitivity. Int J Obes Relat Metab Disord 28: 640-648.
-
(2004)
Int J Obes Relat Metab Disord
, vol.28
, pp. 640-648
-
-
Ravinet Trillou, C.1
Delgorge, C.2
Menet, C.3
Arnone, M.4
Soubrie, P.5
-
19
-
-
20944436157
-
Endocannabinoid activation at hepatic CB1 receptors stimulates fatty acid synthesis and contributes to diet-induced obesity
-
Osei-Hyiaman D, DePetrillo M, Pacher P, Liu J, Radaeva S, et al. (2005) Endocannabinoid activation at hepatic CB1 receptors stimulates fatty acid synthesis and contributes to diet-induced obesity. J Clin Invest 115: 1298-1305.
-
(2005)
J Clin Invest
, vol.115
, pp. 1298-1305
-
-
Osei-Hyiaman, D.1
DePetrillo, M.2
Pacher, P.3
Liu, J.4
Radaeva, S.5
-
20
-
-
38649114788
-
Paracrine activation of hepatic CB1 receptors by stellate cell-derived endocannabinoids mediates alcoholic fatty liver
-
Jeong WI, Osei-Hyiaman D, Park O, Liu J, Batkai S, et al. (2008) Paracrine activation of hepatic CB1 receptors by stellate cell-derived endocannabinoids mediates alcoholic fatty liver. Cell Metab 7: 227-235.
-
(2008)
Cell Metab
, vol.7
, pp. 227-235
-
-
Jeong, W.I.1
Osei-Hyiaman, D.2
Park, O.3
Liu, J.4
Batkai, S.5
-
21
-
-
51349153318
-
Hepatic CB1 receptor is required for development of diet-induced steatosis, dyslipidemia, and insulin and leptin resistance in mice
-
Osei-Hyiaman D, Liu J, Zhou L, Godlewski G, Harvey-White J, et al. (2008) Hepatic CB1 receptor is required for development of diet-induced steatosis, dyslipidemia, and insulin and leptin resistance in mice. J Clin Invest 118: 3160-3169.
-
(2008)
J Clin Invest
, vol.118
, pp. 3160-3169
-
-
Osei-Hyiaman, D.1
Liu, J.2
Zhou, L.3
Godlewski, G.4
Harvey-White, J.5
-
22
-
-
77955286305
-
Peripheral CB1 cannabinoid receptor blockade improves cardiometabolic risk in mouse models of obesity
-
Tam J, Vemuri VK, Liu J, Batkai S, Mukhopadhyay B, et al. (2010) Peripheral CB1 cannabinoid receptor blockade improves cardiometabolic risk in mouse models of obesity. J Clin Invest 120: 2953-2966.
-
(2010)
J Clin Invest
, vol.120
, pp. 2953-2966
-
-
Tam, J.1
Vemuri, V.K.2
Liu, J.3
Batkai, S.4
Mukhopadhyay, B.5
-
23
-
-
44849141696
-
Enzymatic pathways that regulate endocannabinoid signaling in the nervous system
-
Ahn K, McKinney MK, Cravatt BF, (2008) Enzymatic pathways that regulate endocannabinoid signaling in the nervous system. Chem Rev 108: 1687-1707.
-
(2008)
Chem Rev
, vol.108
, pp. 1687-1707
-
-
Ahn, K.1
McKinney, M.K.2
Cravatt, B.F.3
-
24
-
-
0028291118
-
The pharmacological activity of anandamide, a putative endogenous cannabinoid, in mice
-
Smith PB, Compton DR, Welch SP, Razdan RK, Mechoulam R, et al. (1994) The pharmacological activity of anandamide, a putative endogenous cannabinoid, in mice. J Pharmacol Exp Ther 270: 219-227.
-
(1994)
J Pharmacol Exp Ther
, vol.270
, pp. 219-227
-
-
Smith, P.B.1
Compton, D.R.2
Welch, S.P.3
Razdan, R.K.4
Mechoulam, R.5
-
25
-
-
43749096323
-
Activation of the endocannabinoid system by organophosphorus nerve agents
-
Nomura DK, Blankman JL, Simon GM, Fujioka K, Issa RS, et al. (2008) Activation of the endocannabinoid system by organophosphorus nerve agents. Nat Chem Biol 4: 373-378.
-
(2008)
Nat Chem Biol
, vol.4
, pp. 373-378
-
-
Nomura, D.K.1
Blankman, J.L.2
Simon, G.M.3
Fujioka, K.4
Issa, R.S.5
-
26
-
-
55749095211
-
Overactive endocannabinoid signaling impairs apolipoprotein E-mediated clearance of triglyceride-rich lipoproteins
-
Ruby MA, Nomura DK, Hudak CS, Mangravite LM, Chiu S, et al. (2008) Overactive endocannabinoid signaling impairs apolipoprotein E-mediated clearance of triglyceride-rich lipoproteins. Proc Natl Acad Sci U S A 105: 14561-14566.
-
(2008)
Proc Natl Acad Sci U S A
, vol.105
, pp. 14561-14566
-
-
Ruby, M.A.1
Nomura, D.K.2
Hudak, C.S.3
Mangravite, L.M.4
Chiu, S.5
-
27
-
-
0242268497
-
Toxicological and structural features of organophosphorus and organosulfur cannabinoid CB1 receptor ligands
-
Segall Y, Quistad GB, Sparks SE, Nomura DK, Casida JE, (2003) Toxicological and structural features of organophosphorus and organosulfur cannabinoid CB1 receptor ligands. Toxicol Sci 76: 131-137.
-
(2003)
Toxicol Sci
, vol.76
, pp. 131-137
-
-
Segall, Y.1
Quistad, G.B.2
Sparks, S.E.3
Nomura, D.K.4
Casida, J.E.5
-
28
-
-
0033545866
-
Increased mortality, hypoactivity, and hypoalgesia in cannabinoid CB1 receptor knockout mice
-
Zimmer A, Zimmer AM, Hohmann AG, Herkenham M, Bonner TI, (1999) Increased mortality, hypoactivity, and hypoalgesia in cannabinoid CB1 receptor knockout mice. Proc Natl Acad Sci U S A 96: 5780-5785.
-
(1999)
Proc Natl Acad Sci U S A
, vol.96
, pp. 5780-5785
-
-
Zimmer, A.1
Zimmer, A.M.2
Hohmann, A.G.3
Herkenham, M.4
Bonner, T.I.5
-
29
-
-
79251488405
-
Cannabinoid receptor 1 and 2 agonists increase lipid accumulation in hepatocytes
-
De Gottardi A, Spahr L, Ravier-Dall'Antonia F, Hadengue A, (2010) Cannabinoid receptor 1 and 2 agonists increase lipid accumulation in hepatocytes. Liver Int 30: 1482-1489.
-
(2010)
Liver Int
, vol.30
, pp. 1482-1489
-
-
De Gottardi, A.1
Spahr, L.2
Ravier-Dall'Antonia, F.3
Hadengue, A.4
-
30
-
-
20944436157
-
Endocannabinoid activation at hepatic CB1 receptors stimulates fatty acid synthesis and contributes to diet-induced obesity
-
Osei-Hyiaman D, DePetrillo M, Pacher P, Liu J, Radaeva S, et al. (2005) Endocannabinoid activation at hepatic CB1 receptors stimulates fatty acid synthesis and contributes to diet-induced obesity. Journal of Clinical Investigation 115: 1298-1305.
-
(2005)
Journal of Clinical Investigation
, vol.115
, pp. 1298-1305
-
-
Osei-Hyiaman, D.1
DePetrillo, M.2
Pacher, P.3
Liu, J.4
Radaeva, S.5
-
31
-
-
0035131190
-
Essential role of STAT3 in the control of the acute-phase response as revealed by inducible gene inactivation [correction of activation] in the liver
-
Alonzi T, Maritano D, Gorgoni B, Rizzuto G, Libert C, et al. (2001) Essential role of STAT3 in the control of the acute-phase response as revealed by inducible gene inactivation [correction of activation] in the liver. Mol Cell Biol 21: 1621-1632.
-
(2001)
Mol Cell Biol
, vol.21
, pp. 1621-1632
-
-
Alonzi, T.1
Maritano, D.2
Gorgoni, B.3
Rizzuto, G.4
Libert, C.5
-
32
-
-
44949163013
-
Leptin controls adipose tissue lipogenesis via central, STAT3-independent mechanisms
-
Buettner C, Muse ED, Cheng A, Chen L, Scherer T, et al. (2008) Leptin controls adipose tissue lipogenesis via central, STAT3-independent mechanisms. Nat Med 14: 667-675.
-
(2008)
Nat Med
, vol.14
, pp. 667-675
-
-
Buettner, C.1
Muse, E.D.2
Cheng, A.3
Chen, L.4
Scherer, T.5
-
33
-
-
79955958008
-
Monoglyceride lipase-deficiency in mice impairs lipolysis and attenuates diet-induced insulin resistance
-
Taschler U, Radner FP, Heier C, Schreiber R, Schweiger M, et al. (2011) Monoglyceride lipase-deficiency in mice impairs lipolysis and attenuates diet-induced insulin resistance. J Biol Chem.
-
(2011)
J Biol Chem
-
-
Taschler, U.1
Radner, F.P.2
Heier, C.3
Schreiber, R.4
Schweiger, M.5
-
34
-
-
73949109254
-
Dual blockade of FAAH and MAGL identifies behavioral processes regulated by endocannabinoid crosstalk in vivo
-
Long JZ, Nomura DK, Vann RE, Walentiny DM, Booker L, et al. (2009) Dual blockade of FAAH and MAGL identifies behavioral processes regulated by endocannabinoid crosstalk in vivo. Proc Natl Acad Sci U S A 106: 20270-20275.
-
(2009)
Proc Natl Acad Sci U S A
, vol.106
, pp. 20270-20275
-
-
Long, J.Z.1
Nomura, D.K.2
Vann, R.E.3
Walentiny, D.M.4
Booker, L.5
-
35
-
-
78751514576
-
An anatomical and temporal portrait of physiological substrates for fatty acid amide hydrolase
-
Long JZ, LaCava M, Jin X, Cravatt BF, (2011) An anatomical and temporal portrait of physiological substrates for fatty acid amide hydrolase. J Lipid Res 52: 337-344.
-
(2011)
J Lipid Res
, vol.52
, pp. 337-344
-
-
Long, J.Z.1
LaCava, M.2
Jin, X.3
Cravatt, B.F.4
-
36
-
-
0016138269
-
Delta-9-tetrahydrocannabinol and glucose tolerance
-
Hollister LE, Reaven GM, (1974) Delta-9-tetrahydrocannabinol and glucose tolerance. Clin Pharmacol Ther 16: 297-302.
-
(1974)
Clin Pharmacol Ther
, vol.16
, pp. 297-302
-
-
Hollister, L.E.1
Reaven, G.M.2
-
37
-
-
13244249625
-
Effects of the cannabinoid CB1 receptor antagonist SR141716 on oxygen consumption and soleus muscle glucose uptake in Lep(ob)/Lep(ob) mice
-
Liu YL, Connoley IP, Wilson CA, Stock MJ, (2005) Effects of the cannabinoid CB1 receptor antagonist SR141716 on oxygen consumption and soleus muscle glucose uptake in Lep(ob)/Lep(ob) mice. Int J Obes (Lond) 29: 183-187.
-
(2005)
Int J Obes (Lond)
, vol.29
, pp. 183-187
-
-
Liu, Y.L.1
Connoley, I.P.2
Wilson, C.A.3
Stock, M.J.4
-
38
-
-
54949091463
-
Effect of the organophosphorus pesticide diazinon on glucose tolerance in type 2 diabetic rats
-
Ueyama J, Kamijima M, Asai K, Mochizuki A, Wang D, et al. (2008) Effect of the organophosphorus pesticide diazinon on glucose tolerance in type 2 diabetic rats. Toxicol Lett 182: 42-47.
-
(2008)
Toxicol Lett
, vol.182
, pp. 42-47
-
-
Ueyama, J.1
Kamijima, M.2
Asai, K.3
Mochizuki, A.4
Wang, D.5
-
39
-
-
0021056308
-
Organophosphate poisoning presenting as diabetic ketoacidosis
-
Zadik Z, Blachar Y, Barak Y, Levin S, (1983) Organophosphate poisoning presenting as diabetic ketoacidosis. J Toxicol Clin Toxicol 20: 381-385.
-
(1983)
J Toxicol Clin Toxicol
, vol.20
, pp. 381-385
-
-
Zadik, Z.1
Blachar, Y.2
Barak, Y.3
Levin, S.4
-
40
-
-
0034572579
-
Glycosuria in organophosphate and carbamate poisoning
-
Shobha TR, Prakash O, (2000) Glycosuria in organophosphate and carbamate poisoning. J Assoc Physicians India 48: 1197-1199.
-
(2000)
J Assoc Physicians India
, vol.48
, pp. 1197-1199
-
-
Shobha, T.R.1
Prakash, O.2
-
41
-
-
0019431966
-
Hyperglycemia in anticholinesterase poisoning
-
Meller D, Fraser I, Kryger M, (1981) Hyperglycemia in anticholinesterase poisoning. Can Med Assoc J 124: 745-748.
-
(1981)
Can Med Assoc J
, vol.124
, pp. 745-748
-
-
Meller, D.1
Fraser, I.2
Kryger, M.3
-
42
-
-
0034834160
-
Toxicologic significance of the hyperglycemia caused by organophosphorous insecticides
-
Seifert J, (2001) Toxicologic significance of the hyperglycemia caused by organophosphorous insecticides. Bull Environ Contam Toxicol 67: 463-469.
-
(2001)
Bull Environ Contam Toxicol
, vol.67
, pp. 463-469
-
-
Seifert, J.1
-
43
-
-
19944430411
-
Hyperlipidemic effects of dietary saturated fats mediated through PGC-1beta coactivation of SREBP
-
Lin J, Yang R, Tarr PT, Wu PH, Handschin C, et al. (2005) Hyperlipidemic effects of dietary saturated fats mediated through PGC-1beta coactivation of SREBP. Cell 120: 261-273.
-
(2005)
Cell
, vol.120
, pp. 261-273
-
-
Lin, J.1
Yang, R.2
Tarr, P.T.3
Wu, P.H.4
Handschin, C.5
-
44
-
-
70350450243
-
Liver-specific loss of long chain acyl-CoA synthetase-1 decreases triacylglycerol synthesis and beta-oxidation and alters phospholipid fatty acid composition
-
Li LO, Ellis JM, Paich HA, Wang S, Gong N, et al. (2009) Liver-specific loss of long chain acyl-CoA synthetase-1 decreases triacylglycerol synthesis and beta-oxidation and alters phospholipid fatty acid composition. J Biol Chem 284: 27816-27826.
-
(2009)
J Biol Chem
, vol.284
, pp. 27816-27826
-
-
Li, L.O.1
Ellis, J.M.2
Paich, H.A.3
Wang, S.4
Gong, N.5
-
45
-
-
33846003510
-
Overexpression of rat long chain acyl-coa synthetase 1 alters fatty acid metabolism in rat primary hepatocytes
-
Li LO, Mashek DG, An J, Doughman SD, Newgard CB, et al. (2006) Overexpression of rat long chain acyl-coa synthetase 1 alters fatty acid metabolism in rat primary hepatocytes. J Biol Chem 281: 37246-37255.
-
(2006)
J Biol Chem
, vol.281
, pp. 37246-37255
-
-
Li, L.O.1
Mashek, D.G.2
An, J.3
Doughman, S.D.4
Newgard, C.B.5
-
46
-
-
67650272779
-
Antagonism of the cannabinoid CB-1 receptor protects rat liver against ischaemia-reperfusion injury complicated by endotoxaemia
-
Caraceni P, Pertosa AM, Giannone F, Domenicali M, Grattagliano I, et al. (2009) Antagonism of the cannabinoid CB-1 receptor protects rat liver against ischaemia-reperfusion injury complicated by endotoxaemia. Gut 58: 1135-1143.
-
(2009)
Gut
, vol.58
, pp. 1135-1143
-
-
Caraceni, P.1
Pertosa, A.M.2
Giannone, F.3
Domenicali, M.4
Grattagliano, I.5
-
47
-
-
0141507020
-
Role of cannabinoid CB1 receptors and tumor necrosis factor-alpha in the gut and systemic anti-inflammatory activity of SR 141716 (rimonabant) in rodents
-
Croci T, Landi M, Galzin AM, Marini P, (2003) Role of cannabinoid CB1 receptors and tumor necrosis factor-alpha in the gut and systemic anti-inflammatory activity of SR 141716 (rimonabant) in rodents. Br J Pharmacol 140: 115-122.
-
(2003)
Br J Pharmacol
, vol.140
, pp. 115-122
-
-
Croci, T.1
Landi, M.2
Galzin, A.M.3
Marini, P.4
-
48
-
-
11144355734
-
The endogenous cannabinoid system protects against colonic inflammation
-
Massa F, Marsicano G, Hermann H, Cannich A, Monory K, et al. (2004) The endogenous cannabinoid system protects against colonic inflammation. J Clin Invest 113: 1202-1209.
-
(2004)
J Clin Invest
, vol.113
, pp. 1202-1209
-
-
Massa, F.1
Marsicano, G.2
Hermann, H.3
Cannich, A.4
Monory, K.5
-
49
-
-
0031779305
-
Cannabinoids reduce hyperalgesia and inflammation via interaction with peripheral CB1 receptors
-
Richardson JD, Kilo S, Hargreaves KM, (1998) Cannabinoids reduce hyperalgesia and inflammation via interaction with peripheral CB1 receptors. Pain 75: 111-119.
-
(1998)
Pain
, vol.75
, pp. 111-119
-
-
Richardson, J.D.1
Kilo, S.2
Hargreaves, K.M.3
-
50
-
-
25844488706
-
The G alpha(o/i)-coupled cannabinoid receptor-mediated neurite outgrowth involves Rap regulation of Src and Stat3
-
He JC, Gomes I, Nguyen T, Jayaram G, Ram PT, et al. (2005) The G alpha(o/i)-coupled cannabinoid receptor-mediated neurite outgrowth involves Rap regulation of Src and Stat3. J Biol Chem 280: 33426-33434.
-
(2005)
J Biol Chem
, vol.280
, pp. 33426-33434
-
-
He, J.C.1
Gomes, I.2
Nguyen, T.3
Jayaram, G.4
Ram, P.T.5
-
51
-
-
11144357516
-
Role of STAT-3 in regulation of hepatic gluconeogenic genes and carbohydrate metabolism in vivo
-
Inoue H, Ogawa W, Ozaki M, Haga S, Matsumoto M, et al. (2004) Role of STAT-3 in regulation of hepatic gluconeogenic genes and carbohydrate metabolism in vivo. Nat Med 10: 168-174.
-
(2004)
Nat Med
, vol.10
, pp. 168-174
-
-
Inoue, H.1
Ogawa, W.2
Ozaki, M.3
Haga, S.4
Matsumoto, M.5
-
52
-
-
3142723189
-
Central role of suppressors of cytokine signaling proteins in hepatic steatosis, insulin resistance, and the metabolic syndrome in the mouse
-
Ueki K, Kondo T, Tseng YH, Kahn CR, (2004) Central role of suppressors of cytokine signaling proteins in hepatic steatosis, insulin resistance, and the metabolic syndrome in the mouse. Proc Natl Acad Sci U S A 101: 10422-10427.
-
(2004)
Proc Natl Acad Sci U S A
, vol.101
, pp. 10422-10427
-
-
Ueki, K.1
Kondo, T.2
Tseng, Y.H.3
Kahn, C.R.4
-
53
-
-
41349098793
-
Cell type-dependent pro- and anti-inflammatory role of signal transducer and activator of transcription 3 in alcoholic liver injury
-
Horiguchi N, Wang L, Mukhopadhyay P, Park O, Jeong WI, et al. (2008) Cell type-dependent pro- and anti-inflammatory role of signal transducer and activator of transcription 3 in alcoholic liver injury. Gastroenterology 134: 1148-1158.
-
(2008)
Gastroenterology
, vol.134
, pp. 1148-1158
-
-
Horiguchi, N.1
Wang, L.2
Mukhopadhyay, P.3
Park, O.4
Jeong, W.I.5
-
54
-
-
0029115795
-
Identification of a new acute phase protein
-
Liu Q, Nilsen-Hamilton M, (1995) Identification of a new acute phase protein. J Biol Chem 270: 22565-22570.
-
(1995)
J Biol Chem
, vol.270
, pp. 22565-22570
-
-
Liu, Q.1
Nilsen-Hamilton, M.2
-
55
-
-
77953215375
-
Lipocalin-2 deficiency impairs thermogenesis and potentiates diet-induced insulin resistance in mice
-
Guo H, Jin D, Zhang Y, Wright W, Bazuine M, et al. (2010) Lipocalin-2 deficiency impairs thermogenesis and potentiates diet-induced insulin resistance in mice. Diabetes 59: 1376-1385.
-
(2010)
Diabetes
, vol.59
, pp. 1376-1385
-
-
Guo, H.1
Jin, D.2
Zhang, Y.3
Wright, W.4
Bazuine, M.5
-
56
-
-
0034684168
-
The lipocalin protein family: structural and sequence overview
-
Flower DR, North AC, Sansom CE, (2000) The lipocalin protein family: structural and sequence overview. Biochim Biophys Acta 1482: 9-24.
-
(2000)
Biochim Biophys Acta
, vol.1482
, pp. 9-24
-
-
Flower, D.R.1
North, A.C.2
Sansom, C.E.3
-
57
-
-
77951193688
-
Lipocalin-2 deficiency attenuates insulin resistance associated with aging and obesity
-
Law IK, Xu A, Lam KS, Berger T, Mak TW, et al. (2010) Lipocalin-2 deficiency attenuates insulin resistance associated with aging and obesity. Diabetes 59: 872-882.
-
(2010)
Diabetes
, vol.59
, pp. 872-882
-
-
Law, I.K.1
Xu, A.2
Lam, K.S.3
Berger, T.4
Mak, T.W.5
-
58
-
-
0242268553
-
The molecular logic of endocannabinoid signalling
-
Piomelli D, (2003) The molecular logic of endocannabinoid signalling. Nat Rev Neurosci 4: 873-884.
-
(2003)
Nat Rev Neurosci
, vol.4
, pp. 873-884
-
-
Piomelli, D.1
-
59
-
-
66449115318
-
Cannabinoid action induces autophagy-mediated cell death through stimulation of ER stress in human glioma cells
-
Salazar M, Carracedo A, Salanueva IJ, Hernandez-Tiedra S, Lorente M, et al. (2009) Cannabinoid action induces autophagy-mediated cell death through stimulation of ER stress in human glioma cells. J Clin Invest 119: 1359-1372.
-
(2009)
J Clin Invest
, vol.119
, pp. 1359-1372
-
-
Salazar, M.1
Carracedo, A.2
Salanueva, I.J.3
Hernandez-Tiedra, S.4
Lorente, M.5
-
60
-
-
69449095814
-
Cannabinoid modulation of hippocampal long-term memory is mediated by mTOR signaling
-
Puighermanal E, Marsicano G, Busquets-Garcia A, Lutz B, Maldonado R, et al. (2009) Cannabinoid modulation of hippocampal long-term memory is mediated by mTOR signaling. Nat Neurosci 12: 1152-1158.
-
(2009)
Nat Neurosci
, vol.12
, pp. 1152-1158
-
-
Puighermanal, E.1
Marsicano, G.2
Busquets-Garcia, A.3
Lutz, B.4
Maldonado, R.5
-
61
-
-
77949542479
-
FAAH deficiency promotes energy storage and enhances the motivation for food
-
Tourino C, Oveisi F, Lockney J, Piomelli D, Maldonado R, (2010) FAAH deficiency promotes energy storage and enhances the motivation for food. Int J Obes (Lond) 34: 557-568.
-
(2010)
Int J Obes (Lond)
, vol.34
, pp. 557-568
-
-
Tourino, C.1
Oveisi, F.2
Lockney, J.3
Piomelli, D.4
Maldonado, R.5
-
62
-
-
67651100845
-
Characterization of monoacylglycerol lipase inhibition reveals differences in central and peripheral endocannabinoid metabolism
-
Long JZ, Nomura DK, Cravatt BF, (2009) Characterization of monoacylglycerol lipase inhibition reveals differences in central and peripheral endocannabinoid metabolism. Chem Biol 16: 744-753.
-
(2009)
Chem Biol
, vol.16
, pp. 744-753
-
-
Long, J.Z.1
Nomura, D.K.2
Cravatt, B.F.3
-
63
-
-
77956181836
-
Chronic monoacylglycerol lipase blockade causes functional antagonism of the endocannabinoid system
-
Schlosburg JE, Blankman JL, Long JZ, Nomura DK, Pan B, et al. (2010) Chronic monoacylglycerol lipase blockade causes functional antagonism of the endocannabinoid system. Nat Neurosci 13: 1113-1119.
-
(2010)
Nat Neurosci
, vol.13
, pp. 1113-1119
-
-
Schlosburg, J.E.1
Blankman, J.L.2
Long, J.Z.3
Nomura, D.K.4
Pan, B.5
|